| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/23/2023 | 4.63% | Credit Suisse | $23 → $28 | Maintains | Outperform |
| 01/23/2023 | 19.58% | JP Morgan | $24 → $32 | Upgrades | Neutral → Overweight |
| 01/11/2023 | 19.58% | Raymond James | $30 → $32 | Maintains | Strong Buy |
| 11/02/2022 | 12.11% | Raymond James | $29 → $30 | Maintains | Strong Buy |
| 10/11/2022 | 8.37% | Raymond James | $30 → $29 | Maintains | Strong Buy |
| 07/12/2022 | 12.11% | Raymond James | $36 → $30 | Maintains | Strong Buy |
| 04/29/2022 | 34.53% | Raymond James | $37 → $36 | Maintains | Strong Buy |
| 04/12/2022 | 38.27% | Raymond James | $45 → $37 | Maintains | Strong Buy |
| 11/10/2021 | 68.16% | Raymond James | $41 → $45 | Maintains | Strong Buy |
| 11/10/2021 | 30.79% | Credit Suisse | $30 → $35 | Maintains | Outperform |
| 07/29/2021 | 53.21% | Raymond James | $38 → $41 | Maintains | Strong Buy |
| 07/13/2021 | 42% | Raymond James | $34 → $38 | Maintains | Strong Buy |
| 05/11/2021 | 27.06% | Raymond James | → $34 | Upgrades | Outperform → Strong Buy |
| 05/05/2021 | 27.06% | Raymond James | $33 → $34 | Maintains | Outperform |
| 02/12/2021 | 23.32% | Raymond James | $32 → $33 | Maintains | Outperform |
| 12/18/2020 | 0.9% | Truist Securities | → $27 | Initiates Coverage On | → Hold |
| 10/13/2020 | 19.58% | Raymond James | $31 → $32 | Maintains | Outperform |
| 09/23/2020 | -10.31% | Jefferies | → $24 | Initiates Coverage On | → Hold |
| 08/05/2020 | 0.9% | JP Morgan | → $27 | Downgrades | Overweight → Neutral |
| 07/15/2020 | 15.84% | Raymond James | $27 → $31 | Maintains | Outperform |
| 05/06/2020 | 4.63% | Credit Suisse | $31 → $28 | Maintains | Outperform |
| 05/06/2020 | 0.9% | Raymond James | $26 → $27 | Maintains | Outperform |
| 03/13/2020 | 8.37% | Raymond James | $33 → $29 | Maintains | Outperform |
| 02/27/2020 | 23.32% | Raymond James | $34 → $33 | Maintains | Outperform |
| 12/13/2019 | 15.84% | JP Morgan | $30 → $31 | Upgrades | Neutral → Overweight |
| 11/07/2019 | -6.58% | BMO Capital | $24 → $25 | Maintains | Market Perform |
| 10/08/2019 | -10.31% | BMO Capital | → $24 | Initiates Coverage On | → Market Perform |
| 08/12/2019 | 15.84% | Goldman Sachs | → $31 | Initiates Coverage On | → Buy |
| 08/12/2019 | 15.84% | Raymond James | → $31 | Initiates Coverage On | → Outperform |
| 08/12/2019 | 8.37% | JP Morgan | → $29 | Initiates Coverage On | → Neutral |
What is the target price for AssetMark Financial Hldgs (AMK)?
The latest price target for AssetMark Financial Hldgs (NYSE: AMK) was reported by Credit Suisse on February 23, 2023. The analyst firm set a price target for $28.00 expecting AMK to rise to within 12 months (a possible 4.63% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for AssetMark Financial Hldgs (AMK)?
The latest analyst rating for AssetMark Financial Hldgs (NYSE: AMK) was provided by Credit Suisse, and AssetMark Financial Hldgs maintained their outperform rating.
When is the next analyst rating going to be posted or updated for AssetMark Financial Hldgs (AMK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AssetMark Financial Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AssetMark Financial Hldgs was filed on February 23, 2023 so you should expect the next rating to be made available sometime around February 23, 2024.
Is the Analyst Rating AssetMark Financial Hldgs (AMK) correct?
While ratings are subjective and will change, the latest AssetMark Financial Hldgs (AMK) rating was a maintained with a price target of $23.00 to $28.00. The current price AssetMark Financial Hldgs (AMK) is trading at is $26.76, which is within the analyst's predicted range.